Selected Engagements

Engagement record 03

Federal Vaccine Manufacturing Readiness Initiative

Engagement Overview

During the COVID-19 pandemic, technical leadership was provided in support of a national vaccine manufacturing initiative focused on strengthening endotoxin testing capabilities during accelerated production.

The RIBS Method™

Recover

Stabilize analytical capability.

  • Assessed endotoxin testing operations.
  • Evaluated analytical risk.
  • Established immediate testing priorities.

Improve

Strengthen laboratory systems.

  • Developed testing strategies.
  • Established MVD and MVC.
  • Improved SOPs.
  • Enhanced technical review and reporting.
  • Optimized laboratory workflows.

Build

Develop laboratory capability.

  • Trained laboratory personnel.
  • Standardized testing practices.
  • Established sustainable analytical processes.
  • Transferred program ownership.

Scale

Support accelerated manufacturing.

  • Supported FDA inspections.
  • Supported client and government audits.
  • Demonstrated analytical control during accelerated manufacturing.
  • Enabled sustainable long-term testing capability.

The Lasting Impact

Established robust endotoxin testing capabilities supporting critical vaccine manufacturing while developing the internal expertise necessary for continued operational success.

If this resembles your situation, the review is the place to start.

Schedule Review